MIT Startup Exchange December 2025 Demo Day
December 10, 2025
12:00 PM - 1:15 PM
Innovation in Manufacturing Biomedicines: From New Modalities to Scalable, Accessible Therapeutics Stacy Springs Executive Director, MIT Center for Biomedical Innovation (CBI)
Biologic medicines (e.g., monoclonal antibodies, gene and cell therapies, vaccines) are critical to treating and preventing disease. Recent regulatory approvals of exciting new biomedicines such as cell and gene therapies provide new hope to patients who have exhausted alternative therapies or suffer from a rare disease with no other treatment. To help patients access these medicines, biopharmaceutical companies must be able to manufacture very complex molecules safely, reliably, and in the quantities needed, which can range from the very large (industrialized) scale to the very small (personalized) scale. This presentation will review the challenges in manufacturing these complex biologic medicines as well as approaches to modernization of biomanufacturing with the goal of providing broadened access to biologic medicines. Dr. Springs will describe multiple approaches that MIT’s Center for Biomedical Innovation and collaborators are taking to achieve this goal, including continuous manufacturing, novel purification strategies, novel analytical technologies for assessing novel product quality attributes, and rapid methods for sterility and viral safety assessment.
Contact
Want some good news about the environment? In America, we have finally learned to grow our economy while taking less from the Earth year after year: less water, timber, and metal; fewer minerals and resources; even less energy. This talk is a show and tell about this profound change. Andy McAfee will show the evidence that we've started getting more from less and tell how it happened. The unlikely heroes of the tale are the cost pressures that come from intense competition and powerful digital tools that reduce the need for resources. In short, prices and processors are now letting us tread more lightly on the Earth. The story is full of surprises and also insights. In particular, it gives us a playbook for dealing with the major challenges still ahead of us: global warming, pollution, and species loss.
SMEs are the backbone of most economies and employ approximately 60 percent of the working population in OECD countries. However, these businesses often struggle the most to access financing, oftentimes, relying on friends and family to help them flourish and thrive by lending money when others do not. We have created Trust·u to offer a solution to this. Trust·u is an internal venturing effort from BBVA, positioned to address innovation opportunities in an agile manner by mimicking startups. We utilize a digital platform to enable rapid on-boarding and underwriting, combining social elements with financial data, to grant small businesses access to financing based on a new risk assessment model, which takes full advantage of ML techniques and new data sources.
Redefining Small Business Lending through ML and Social Physics.